| Application no. and date | 05853385.2 (espacenet) (Federated) (European Patent Register), 20051207 | | Patent/reg. no. and date | DK/EP 1819353, 20110223 | | Publication date | 20070822 | | Priority no. and date | US 634366 P, 20041207, US 655930 P, 20050223 | | EP pub. no. and date |
EP 1819353 20070822 | | Effective date | | | Applicant/owner | Onyx Therapeutics, Inc., 249 East Grand Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | P006017EPDK1 | | Inventor | LEWIS, Evan R., 631 Miller Avenue
Pacifica, CA 94044, US,
HO, Mark Nguyen, 3330 Shoshana Lane
San Jose, CA 95135, US,
FONSECA, Fabiana N., 30 River Road,
Apt. 8g
New York, NY 10044, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/336 (2006.01) , A61K 31/396 (2006.01) , A61K 38/04 (2006.01) | | Title | Sammensætning til proteasomhæmning | | Int. application no. | US2005044451 | | Int. publication no. | WO2006063154 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
